Skip to main content

IDT Acquires Belgian RNA-TEC to Bolster RNAi Play, Nab European Foothold

NEW YORK (GenomeWeb News) - Integrated DNA Technologies said today that it acquired a Belgian company specializing in RNA field to bolster its own offerings in the field and attain a foothold in Europe.
 
The RNA-TEC acquisition is aimed at broadening IDT’s capabilities in the large-scale RNA synthesis and purification space, especially with increased demand for scale-up of IDT’s Dicer-Substrate RNAi compounds for large screens and animal studies.
 
With RNA-TEC, a spin-off company of the University of Leuven, Belgium, IDT can also expand into the European market. IDT plans to update and expand the infrastructure at RNA-TEC’s headquarters.
 
Terms of the deal were not disclosed.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.